We provide our partners with advanced drug leads and the most sophisticated tools in computational modeling and de novo drug design. Advantages to our partners include increases in the number and diversity of NCE's containing novel chemical scaffolds for their weed discovery pipeline. For more detailed information and to discuss the benefits of our technology to your drug discovery projects, please contact our business development team.

R&D Collaboration

•  Design of NCE's with specific chemical and pharmacological properties based on data (SAR) and information (targets, mode of action, etc.) provided by the partner

•  Customized computational and/or medicinal chemistry solutions to enable the weed discovery process of our partners and client

Co-development

Technical expertise and resources are shared between us and our partners facilitating the weed discovery and development process. We add significant value to the investment in biological target discovery as well as the chemical and biological data of our partners via customized and fully integrated EMD™ solutions.

Licensing

We may out-license our compounds/drug leads at any given stage in the discovery process. These compounds have designed-in nanomolar affinities for their specific target and are extensively evaluated for their physicochemical properties, bioavailability, synthetic feasibility, toxicity, etc. Furthermore, their specificity and activity are confirmed in biological and pharmacological assays.